Edition:
United Kingdom

AVROBIO Inc (AVRO.OQ)

AVRO.OQ on NASDAQ Stock Exchange Global Select Market

21.99USD
19 Jul 2019
Change (% chg)

$-1.45 (-6.19%)
Prev Close
$23.44
Open
$23.07
Day's High
$23.30
Day's Low
$21.44
Volume
250,720
Avg. Vol
75,800
52-wk High
$53.70
52-wk Low
$11.85

About

AVROBIO, Inc. is a clinical stage gene therapy company. The Company is focused on developing curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose. Its gene therapies employ hematopoietic stem cells that are extracted from the patient and then modified with lentiviral vectors to insert a... (more)

Overall

Beta: --
Market Cap(Mil.): $672.38
Shares Outstanding(Mil.): 30.58
Dividend: --
Yield (%): --

Financials

  AVRO.OQ Industry Sector
P/E (TTM): -- 97.98 34.52
EPS (TTM): -2.31 -- --
ROI: -67.93 7.77 12.69
ROE: -150.72 8.27 17.17

Earnings vs. Estimates